🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Montpellier
NCT06618755 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this clinical study is to evaluate the efficacy of reinforced inpatient aftercare versus usual care on the percentage of days of abstinence during the first year following withdrawal in adults with alcohol use disorders undergoing inpatient withdrawal. The hypothesis is that reinforced post-withdrawal follow-up, of the motivational interview type, during the first 4 months following hospitalisation, in addition to the usual care, would allow : * Increase the percentage of days of abstinence in the year following withdrawal. * Reduce the rate of relapse in the year following withdrawal. * An increase in the cumulative and maximum duration of abstinence, an increase in motivation to maintain the change initiated and a reduction in the use of other substances in the year following withdrawal. * A reduction in the impact of risk factors involved in the relapse process in the year

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * With alcohol use disorders defined by at least 2 DSM-V criteria for at least 12 months). * Being treated for withdrawal in hospital. * With a goal of complete abstinence. * With a means of communication (telephone). Exclusion Criteria: * Lack of understanding (written and spoken) of the French language. * Breach of HC withdrawal contract, following failure to comply with the rules of the addictology service and somatic complications of addiction. * Eviction from the department, discharge against medical advice during hospitalisation for withdrawal. * Proven cognitive problems compromising understanding of the implications of the study and the proposed follow-up. proposed follow-up. * Serious decompensated somatic pathology. * Non-membership or non-beneficiaries of a national health insurance scheme. * Person protected by law, under guardianship or curatorship. * Not having signed free and informed consent to participate in the research. * Simultaneous participation in another clinical trial.
💊

What it tests

  • Experimental group : PSH (usual care) with motivational interviewing
📍

Where

1 site
Thomas RISDORFER DE ISSDENTZI
Montpellier, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy